Characteristics at diagnosis of patients randomized to maintenance treatment before and after amendment
| . | Median WBCs × 103/μL (range) . | Median platelets × 103/μL, (range) . | Median age, y (range) . | Male/female . |
|---|---|---|---|---|
| Before | ||||
| A | 2.5 (0.6-140.0) | 20.0 (2.0-167.0) | 32.9 (7.5-68.8) | 53/30 |
| A + C | 3.0 (0.4-125.4) | 29.0 (3.0-241.0) | 41.6 (2.8-71.6) | 38/43 |
| C | 2.2 (0.3-108.0) | 21.0 (4.0-178.0) | 36.3 (5.1-73.9) | 46/32 |
| O | 2.5 (0.4-43.9) | 21.5 (1.0-480.0) | 35.8 (2.2-67.6) | 41/35 |
| P | .7570 | .1117 | .4736 | .1576 |
| After | ||||
| A | 4.3 (0.3-570.0) | 22.0 (2.0-173.0) | 33.4 (1.9-70.3) | 70/65 |
| A + C | 2.9 (0.3-180.0) | 23.0 (3.0-227.0) | 33.7 (2.0-71.8) | 67/66 |
| P | .1223 | .5419 | .1390 | .8090 |
| . | Median WBCs × 103/μL (range) . | Median platelets × 103/μL, (range) . | Median age, y (range) . | Male/female . |
|---|---|---|---|---|
| Before | ||||
| A | 2.5 (0.6-140.0) | 20.0 (2.0-167.0) | 32.9 (7.5-68.8) | 53/30 |
| A + C | 3.0 (0.4-125.4) | 29.0 (3.0-241.0) | 41.6 (2.8-71.6) | 38/43 |
| C | 2.2 (0.3-108.0) | 21.0 (4.0-178.0) | 36.3 (5.1-73.9) | 46/32 |
| O | 2.5 (0.4-43.9) | 21.5 (1.0-480.0) | 35.8 (2.2-67.6) | 41/35 |
| P | .7570 | .1117 | .4736 | .1576 |
| After | ||||
| A | 4.3 (0.3-570.0) | 22.0 (2.0-173.0) | 33.4 (1.9-70.3) | 70/65 |
| A + C | 2.9 (0.3-180.0) | 23.0 (3.0-227.0) | 33.7 (2.0-71.8) | 67/66 |
| P | .1223 | .5419 | .1390 | .8090 |
A indicates ATRA; A + C = ATRA + chemotherapy; C = chemotherapy; and O = observation.